Skip to main content
Clinical Trials/NCT06566144
NCT06566144
Recruiting
Not Applicable

Effect of a Standard Treatment for Non-specific Low Back Pain Combined With Multimodal Osteopathy Treatment on Pain Intensity and Functional Capacity: A Randomized, Controlled, Blinded Trial"

University of Nove de Julho1 site in 1 country44 target enrollmentSeptember 10, 2024
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
University of Nove de Julho
Enrollment
44
Locations
1
Primary Endpoint
Pain intensity
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Background: Low back pain is one of the most common musculoskeletal health problem with the highest prevalence in the adult population; globally, it represents a relevant cause of medical, social and economic burden. The aim of the proposed study is to determine the effect of a standard treatment for non-specific low back (CNSLBP) combined with multimodal osteopathy treatment on pain intensity and functional capacity.

Methods: This will be a blind randomized clinical trial, with 44 patients with CNSLBP, randomly assigned into two groups: Experimental group (EG) treated with therapeutic exercises and multimodal osteopathy treatment (n=22) and Control group (CG) treated with therapeutic exercises (n=22). Participants will receive treatment twice a week (total of 16 sessions). The primary outcome is pain, measured by numeric rating scale (NRS: score 0-11 points). Secondary outcomes are: Patient-specific functional scale (scored from 0 to 30), Oswestry Disability Questionnaire (ODQ), finger-to-floor distance test (FFD). Participants will be evaluated pre- and post-treatment and after 1 and 3 months (follow-up).

Results: Analysis will be by intention to treat using linear mixed models. Comparisons between groups before and after treatment will demonstrate whether osteopathy treatment exerts a supplementary effect on pain and functional capacity in patients with CNSLBP. The data will be published after the study is completed. The study will support the practice of evidence-based physical therapy for individuals with CNSLBP.

Registry
clinicaltrials.gov
Start Date
September 10, 2024
End Date
January 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fabiano Politti

Prof. Fabiano Politti, FT

University of Nove de Julho

Eligibility Criteria

Inclusion Criteria

  • Individuals within the age range of 18-70 years;
  • Chronic low back pain in the region between the 12th rib and the gluteal fold, with a minimum duration of 6 weeks with or without referral of pain in the lower limbs;
  • no specific cause detectable, such as infection, neoplasia, metastasis, osteoporosis, rheumatoid arthritis, fracture, inflammatory process or radicular syndrome.
  • baseline pain: minimum intensity score of 3 out of 10 (0 = no pain, 10 = most intense pain) considered and verified by the Numerical Pain Rating Scale (NPRS).

Exclusion Criteria

  • Previous history of spinal disorders (local trauma, cauda equina syndrome, spinal canal stenosis, congenital abnormalities tumor);
  • Inflammatory or infectious diseases (rheumatoid arthritis, fibromyalgia and vertebral osteomyelitis);
  • Previous lumbar spine surgery;
  • Pregnant women;
  • Regular opioid analgesics (≥2 times per week) or opioid patches;
  • Receiving disability benefits for back pain or even for another health reason;
  • Previous injections for back pain, such as facet joint blocks, nerve root or epidural steroid injection in the previous year;
  • Having undergone physical therapy, massage, acupuncture or any other therapeutic intervention for back pain in the previous two weeks;
  • Osteopathy techniques that are not used as a treatment for low back pain;
  • Neuropathic pain tested with Laségue and Valsalva clinical tests.

Outcomes

Primary Outcomes

Pain intensity

Time Frame: Baseline and one week and 3 months (follow-up).

Changes in pain intensity, will be assessed using the NPRS (Numerical Pain Rating Scale). This is an 11-point scale where 0 means "no pain" and 10 means "worst possible pain". NPRS outcome measures will be evaluated pre- and post-treatment.

Secondary Outcomes

  • Lumbar mobility(Baseline and one week)
  • Disability caused by low back pain(Baseline and one week)
  • Patient-Specific Functional Scale(Baseline and one week)
  • Prognostic Risk Assessment(Baseline and one week)

Study Sites (1)

Loading locations...

Similar Trials